Version 5.4
Bos taurus Protein: CLDN12
Summary
InnateDB Protein IDBP-680246.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol CLDN12
Protein Name Claudin-12
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000025950
InnateDB Gene IDBG-628869 (CLDN12)
Protein Structure
UniProt Annotation
Function Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium- independent cell-adhesion activity. {ECO:0000250}.
Subcellular Localization Cell junction, tight junction {ECO:0000250}. Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005198 structural molecule activity
Biological Process
Cellular Component
GO:0005886 plasma membrane
GO:0005923 tight junction
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0016328 lateral plasma membrane
GO:0030054 cell junction
GO:0071944 cell periphery
Protein Structure and Domains
PDB ID
InterPro IPR013287 Claudin-12
PFAM
PRINTS PR01872
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q0IIL2
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 538709
UniGene Bt.1196
RefSeq NP_001069591
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC122589
GenPept AAI22590

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca